nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—RET—enteric nervous system—narcolepsy	0.212	0.27	CbGeAlD
Ponatinib—RET—autonomic nervous system—narcolepsy	0.0743	0.0946	CbGeAlD
Ponatinib—FGFR4—brainstem—narcolepsy	0.0381	0.0486	CbGeAlD
Ponatinib—FGFR3—forebrain—narcolepsy	0.0251	0.032	CbGeAlD
Ponatinib—BCR—forebrain—narcolepsy	0.0217	0.0277	CbGeAlD
Ponatinib—FGFR3—medulla oblongata—narcolepsy	0.0181	0.0231	CbGeAlD
Ponatinib—FGFR2—brainstem—narcolepsy	0.017	0.0217	CbGeAlD
Ponatinib—FGFR3—midbrain—narcolepsy	0.0166	0.0211	CbGeAlD
Ponatinib—FGFR2—forebrain—narcolepsy	0.0164	0.0209	CbGeAlD
Ponatinib—BCR—medulla oblongata—narcolepsy	0.0157	0.02	CbGeAlD
Ponatinib—FGFR4—brain—narcolepsy	0.0153	0.0195	CbGeAlD
Ponatinib—BCR—midbrain—narcolepsy	0.0144	0.0183	CbGeAlD
Ponatinib—PDGFRA—forebrain—narcolepsy	0.0143	0.0182	CbGeAlD
Ponatinib—SRC—forebrain—narcolepsy	0.014	0.0178	CbGeAlD
Ponatinib—FGFR1—medulla oblongata—narcolepsy	0.014	0.0178	CbGeAlD
Ponatinib—KDR—forebrain—narcolepsy	0.0129	0.0164	CbGeAlD
Ponatinib—FGFR1—midbrain—narcolepsy	0.0128	0.0163	CbGeAlD
Ponatinib—RET—medulla oblongata—narcolepsy	0.0125	0.0159	CbGeAlD
Ponatinib—KIT—brainstem—narcolepsy	0.0118	0.0151	CbGeAlD
Ponatinib—RET—midbrain—narcolepsy	0.0114	0.0146	CbGeAlD
Ponatinib—TEK—medulla oblongata—narcolepsy	0.0114	0.0145	CbGeAlD
Ponatinib—LYN—brain—narcolepsy	0.0105	0.0133	CbGeAlD
Ponatinib—FGFR3—brain—narcolepsy	0.0104	0.0133	CbGeAlD
Ponatinib—TEK—midbrain—narcolepsy	0.0104	0.0133	CbGeAlD
Ponatinib—ABL1—brainstem—narcolepsy	0.0103	0.0131	CbGeAlD
Ponatinib—KDR—medulla oblongata—narcolepsy	0.00931	0.0119	CbGeAlD
Ponatinib—BCR—brain—narcolepsy	0.00902	0.0115	CbGeAlD
Ponatinib—KDR—midbrain—narcolepsy	0.00851	0.0108	CbGeAlD
Ponatinib—KIT—medulla oblongata—narcolepsy	0.00825	0.0105	CbGeAlD
Ponatinib—FGFR1—brain—narcolepsy	0.00802	0.0102	CbGeAlD
Ponatinib—KIT—midbrain—narcolepsy	0.00754	0.0096	CbGeAlD
Ponatinib—ABL1—medulla oblongata—narcolepsy	0.00718	0.00915	CbGeAlD
Ponatinib—RET—brain—narcolepsy	0.00718	0.00915	CbGeAlD
Ponatinib—FGFR2—brain—narcolepsy	0.00682	0.00869	CbGeAlD
Ponatinib—ABL1—midbrain—narcolepsy	0.00656	0.00836	CbGeAlD
Ponatinib—TEK—brain—narcolepsy	0.00654	0.00833	CbGeAlD
Ponatinib—PDGFRA—brain—narcolepsy	0.00593	0.00755	CbGeAlD
Ponatinib—SRC—brain—narcolepsy	0.00581	0.0074	CbGeAlD
Ponatinib—KDR—brain—narcolepsy	0.00535	0.00681	CbGeAlD
Ponatinib—KIT—brain—narcolepsy	0.00474	0.00603	CbGeAlD
Ponatinib—ABCG2—medulla oblongata—narcolepsy	0.00453	0.00577	CbGeAlD
Ponatinib—CYP2D6—brainstem—narcolepsy	0.00445	0.00567	CbGeAlD
Ponatinib—CYP2D6—forebrain—narcolepsy	0.0043	0.00547	CbGeAlD
Ponatinib—ABCG2—midbrain—narcolepsy	0.00414	0.00527	CbGeAlD
Ponatinib—ABL1—brain—narcolepsy	0.00412	0.00525	CbGeAlD
Ponatinib—ABCB1—forebrain—narcolepsy	0.00309	0.00394	CbGeAlD
Ponatinib—CYP2C8—brain—narcolepsy	0.00267	0.00341	CbGeAlD
Ponatinib—ABCG2—brain—narcolepsy	0.0026	0.00331	CbGeAlD
Ponatinib—LYN—Cytokine Signaling in Immune system—SOCS2—narcolepsy	0.00227	0.0106	CbGpPWpGaD
Ponatinib—RET—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00224	0.0104	CbGpPWpGaD
Ponatinib—ABCB1—medulla oblongata—narcolepsy	0.00223	0.00284	CbGeAlD
Ponatinib—LCK—Downstream TCR signaling—HLA-DQB1—narcolepsy	0.00221	0.0103	CbGpPWpGaD
Ponatinib—TEK—Angiopoietin receptor Tie2-mediated signaling—TNF—narcolepsy	0.00213	0.00993	CbGpPWpGaD
Ponatinib—LCK—Generation of second messenger molecules—HLA-DRB1—narcolepsy	0.00205	0.00954	CbGpPWpGaD
Ponatinib—ABCB1—midbrain—narcolepsy	0.00204	0.0026	CbGeAlD
Ponatinib—PDGFRA—Allograft Rejection—HLA-DQA1—narcolepsy	0.00194	0.00901	CbGpPWpGaD
Ponatinib—LYN—Costimulation by the CD28 family—HLA-DQA1—narcolepsy	0.00192	0.00896	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—SOCS2—narcolepsy	0.00186	0.00867	CbGpPWpGaD
Ponatinib—PDGFRA—Allograft Rejection—HLA-DQB1—narcolepsy	0.00181	0.00842	CbGpPWpGaD
Ponatinib—LYN—Costimulation by the CD28 family—HLA-DQB1—narcolepsy	0.0018	0.00838	CbGpPWpGaD
Ponatinib—CYP2D6—brain—narcolepsy	0.00178	0.00227	CbGeAlD
Ponatinib—FGFR4—Immune System—SOCS2—narcolepsy	0.00178	0.00828	CbGpPWpGaD
Ponatinib—LCK—TCR signaling—HLA-DQA1—narcolepsy	0.00177	0.00822	CbGpPWpGaD
Ponatinib—LCK—Downstream TCR signaling—HLA-DRB1—narcolepsy	0.00168	0.00783	CbGpPWpGaD
Ponatinib—LCK—TCR signaling—HLA-DQB1—narcolepsy	0.00165	0.00769	CbGpPWpGaD
Ponatinib—LCK—Costimulation by the CD28 family—HLA-DQA1—narcolepsy	0.00158	0.00734	CbGpPWpGaD
Ponatinib—LCK—Costimulation by the CD28 family—HLA-DQB1—narcolepsy	0.00148	0.00687	CbGpPWpGaD
Ponatinib—SRC—Costimulation by the CD28 family—HLA-DQA1—narcolepsy	0.0014	0.0065	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00138	0.00642	CbGpPWpGaD
Ponatinib—PDGFRA—Allograft Rejection—HLA-DRB1—narcolepsy	0.00138	0.00641	CbGpPWpGaD
Ponatinib—LYN—Costimulation by the CD28 family—HLA-DRB1—narcolepsy	0.00137	0.00637	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—SOCS2—narcolepsy	0.00132	0.00612	CbGpPWpGaD
Ponatinib—SRC—Costimulation by the CD28 family—HLA-DQB1—narcolepsy	0.00131	0.00608	CbGpPWpGaD
Ponatinib—ABCB1—brain—narcolepsy	0.00128	0.00163	CbGeAlD
Ponatinib—BCR—Signaling Pathways—HCRTR2—narcolepsy	0.00128	0.00596	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—HCRTR1—narcolepsy	0.00128	0.00596	CbGpPWpGaD
Ponatinib—LCK—TCR signaling—HLA-DRB1—narcolepsy	0.00126	0.00585	CbGpPWpGaD
Ponatinib—LCK—IL12-mediated signaling events—HLA-DRB1—narcolepsy	0.00124	0.00577	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—P2RY11—narcolepsy	0.00124	0.00576	CbGpPWpGaD
Ponatinib—LYN—CXCR4-mediated signaling events—HLA-DRB1—narcolepsy	0.00116	0.00538	CbGpPWpGaD
Ponatinib—LCK—TCR signaling in naïve CD4+ T cells—HLA-DRB1—narcolepsy	0.00115	0.00535	CbGpPWpGaD
Ponatinib—LCK—Costimulation by the CD28 family—HLA-DRB1—narcolepsy	0.00112	0.00522	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—HCRT—narcolepsy	0.00105	0.00489	CbGpPWpGaD
Ponatinib—SRC—Costimulation by the CD28 family—HLA-DRB1—narcolepsy	0.000993	0.00462	CbGpPWpGaD
Ponatinib—RET—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000963	0.00448	CbGpPWpGaD
Ponatinib—LCK—CXCR4-mediated signaling events—HLA-DRB1—narcolepsy	0.000947	0.00441	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000937	0.00436	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—PENK—narcolepsy	0.000937	0.00436	CbGpPWpGaD
Ponatinib—FGFR2—Cardiac Hypertrophic Response—TNF—narcolepsy	0.000935	0.00435	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—SOCS2—narcolepsy	0.000905	0.00421	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HCRTR1—narcolepsy	0.000902	0.0042	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HCRTR2—narcolepsy	0.000902	0.0042	CbGpPWpGaD
Ponatinib—KIT—Immune System—SOCS2—narcolepsy	0.000889	0.00414	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—P2RY11—narcolepsy	0.000871	0.00406	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—SOCS2—narcolepsy	0.000843	0.00392	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—SOCS2—narcolepsy	0.000841	0.00391	CbGpPWpGaD
Ponatinib—SRC—CXCR4-mediated signaling events—HLA-DRB1—narcolepsy	0.000839	0.0039	CbGpPWpGaD
Ponatinib—FGFR4—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000801	0.00373	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TRH—narcolepsy	0.000797	0.00371	CbGpPWpGaD
Ponatinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—narcolepsy	0.000786	0.00366	CbGpPWpGaD
Ponatinib—FGFR4—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000749	0.00349	CbGpPWpGaD
Ponatinib—LYN—Immune System—SOCS2—narcolepsy	0.000742	0.00345	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HCRT—narcolepsy	0.000741	0.00345	CbGpPWpGaD
Ponatinib—ABL1—Immune System—SOCS2—narcolepsy	0.000738	0.00344	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.000733	0.00341	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—HRH3—narcolepsy	0.000699	0.00325	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.000685	0.00319	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HCRTR2—narcolepsy	0.000667	0.00311	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HCRTR1—narcolepsy	0.000667	0.00311	CbGpPWpGaD
Ponatinib—FGFR2—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.000666	0.0031	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—PENK—narcolepsy	0.00066	0.00307	CbGpPWpGaD
Ponatinib—PDGFRA—Allograft Rejection—TNF—narcolepsy	0.000651	0.00303	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—P2RY11—narcolepsy	0.000645	0.003	CbGpPWpGaD
Ponatinib—SRC—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000642	0.00299	CbGpPWpGaD
Ponatinib—SRC—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000642	0.00299	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.00062	0.00289	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—CHKB—narcolepsy	0.000614	0.00286	CbGpPWpGaD
Ponatinib—LCK—Immune System—SOCS2—narcolepsy	0.000608	0.00283	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000592	0.00276	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HCRTR1—narcolepsy	0.000581	0.00271	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HCRTR2—narcolepsy	0.000581	0.00271	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.00058	0.0027	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—NPS—narcolepsy	0.000579	0.0027	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TAC1—narcolepsy	0.000579	0.0027	CbGpPWpGaD
Ponatinib—FGFR4—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000569	0.00265	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000566	0.00263	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TRH—narcolepsy	0.000562	0.00261	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—P2RY11—narcolepsy	0.000562	0.00261	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000554	0.00258	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HCRT—narcolepsy	0.000548	0.00255	CbGpPWpGaD
Ponatinib—SRC—Immune System—SOCS2—narcolepsy	0.000538	0.00251	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.000521	0.00243	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.000508	0.00237	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HRH3—narcolepsy	0.000492	0.00229	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—PENK—narcolepsy	0.000488	0.00227	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—HLA-DQA1—narcolepsy	0.000486	0.00226	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HCRT—narcolepsy	0.000477	0.00222	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.000476	0.00221	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HCRTR1—narcolepsy	0.000459	0.00214	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HCRTR2—narcolepsy	0.000459	0.00214	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—HLA-DQB1—narcolepsy	0.000454	0.00211	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HCRTR1—narcolepsy	0.000451	0.0021	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HCRTR2—narcolepsy	0.000451	0.0021	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—P2RY11—narcolepsy	0.000443	0.00206	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000441	0.00205	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—P2RY11—narcolepsy	0.000435	0.00203	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HCRTR1—narcolepsy	0.000428	0.00199	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HCRTR2—narcolepsy	0.000428	0.00199	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HCRTR2—narcolepsy	0.000427	0.00199	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HCRTR1—narcolepsy	0.000427	0.00199	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—PENK—narcolepsy	0.000426	0.00198	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000421	0.00196	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—CPT1B—narcolepsy	0.000417	0.00194	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TRH—narcolepsy	0.000415	0.00193	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—P2RY11—narcolepsy	0.000413	0.00192	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—P2RY11—narcolepsy	0.000412	0.00192	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—NPS—narcolepsy	0.000408	0.0019	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TAC1—narcolepsy	0.000408	0.0019	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000407	0.0019	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CHKB—narcolepsy	0.000406	0.00189	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—HLA-DQA1—narcolepsy	0.0004	0.00186	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000385	0.00179	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000381	0.00177	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00038	0.00177	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000379	0.00176	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HCRT—narcolepsy	0.000377	0.00175	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HCRTR1—narcolepsy	0.000376	0.00175	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HCRTR2—narcolepsy	0.000376	0.00175	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000374	0.00174	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HCRT—narcolepsy	0.00037	0.00172	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HRH3—narcolepsy	0.000364	0.0017	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—P2RY11—narcolepsy	0.000364	0.00169	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TRH—narcolepsy	0.000362	0.00168	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000362	0.00168	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—HLA-DQA1—narcolepsy	0.000359	0.00167	CbGpPWpGaD
Ponatinib—FGFR1—MAPK Signaling Pathway—TNF—narcolepsy	0.000357	0.00166	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000355	0.00165	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000354	0.00165	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HCRT—narcolepsy	0.000351	0.00164	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HCRT—narcolepsy	0.00035	0.00163	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—HTR2A—narcolepsy	0.000348	0.00162	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—HLA-DRB1—narcolepsy	0.000345	0.00161	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—HLA-DQB1—narcolepsy	0.000336	0.00156	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—PENK—narcolepsy	0.000336	0.00156	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000334	0.00155	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—PENK—narcolepsy	0.00033	0.00154	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000322	0.0015	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000321	0.00149	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HRH3—narcolepsy	0.000317	0.00148	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—PENK—narcolepsy	0.000313	0.00146	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000312	0.00145	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—PENK—narcolepsy	0.000312	0.00145	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HCRT—narcolepsy	0.000309	0.00144	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HCRTR1—narcolepsy	0.000309	0.00144	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HCRTR2—narcolepsy	0.000309	0.00144	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—NPS—narcolepsy	0.000302	0.0014	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TAC1—narcolepsy	0.000302	0.0014	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—P2RY11—narcolepsy	0.000298	0.00139	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CHKB—narcolepsy	0.000291	0.00135	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—HLA-DRB1—narcolepsy	0.00029	0.00135	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TRH—narcolepsy	0.000286	0.00133	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000285	0.00132	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000282	0.00131	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TRH—narcolepsy	0.000281	0.00131	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CPT1B—narcolepsy	0.000276	0.00128	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PENK—narcolepsy	0.000275	0.00128	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000274	0.00127	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HCRTR2—narcolepsy	0.000273	0.00127	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HCRTR1—narcolepsy	0.000273	0.00127	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—HLA-DRB1—narcolepsy	0.00027	0.00126	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000269	0.00125	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TRH—narcolepsy	0.000266	0.00124	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TRH—narcolepsy	0.000266	0.00124	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—P2RY11—narcolepsy	0.000264	0.00123	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TAC1—narcolepsy	0.000263	0.00122	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—NPS—narcolepsy	0.000263	0.00122	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000256	0.00119	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—HLA-DRB1—narcolepsy	0.000255	0.00119	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HCRT—narcolepsy	0.000253	0.00118	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CHKB—narcolepsy	0.000252	0.00117	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HRH3—narcolepsy	0.00025	0.00117	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HLA-DQA1—narcolepsy	0.000247	0.00115	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000246	0.00115	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HRH3—narcolepsy	0.000246	0.00114	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HTR2A—narcolepsy	0.000245	0.00114	CbGpPWpGaD
Ponatinib—KIT—Immune System—HLA-DQA1—narcolepsy	0.000243	0.00113	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000242	0.00113	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000238	0.00111	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TRH—narcolepsy	0.000234	0.00109	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HRH3—narcolepsy	0.000233	0.00109	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HRH3—narcolepsy	0.000233	0.00108	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HLA-DQB1—narcolepsy	0.000231	0.00108	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HLA-DQA1—narcolepsy	0.00023	0.00107	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HLA-DQA1—narcolepsy	0.00023	0.00107	CbGpPWpGaD
Ponatinib—KIT—Immune System—HLA-DQB1—narcolepsy	0.000227	0.00106	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000227	0.00106	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PENK—narcolepsy	0.000226	0.00105	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HCRT—narcolepsy	0.000224	0.00104	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CHKB—narcolepsy	0.00022	0.00102	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HLA-DQB1—narcolepsy	0.000215	0.001	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HLA-DQB1—narcolepsy	0.000215	0.001	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NPS—narcolepsy	0.000208	0.000966	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TAC1—narcolepsy	0.000208	0.000966	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CHKB—narcolepsy	0.000207	0.000963	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000205	0.000956	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HRH3—narcolepsy	0.000205	0.000956	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—TNF—narcolepsy	0.000205	0.000952	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TAC1—narcolepsy	0.000204	0.000949	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NPS—narcolepsy	0.000204	0.000949	CbGpPWpGaD
Ponatinib—LYN—Immune System—HLA-DQA1—narcolepsy	0.000203	0.000943	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HLA-DQA1—narcolepsy	0.000202	0.000938	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PENK—narcolepsy	0.0002	0.00093	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CPT1B—narcolepsy	0.000198	0.00092	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000195	0.000906	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TAC1—narcolepsy	0.000193	0.0009	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NPS—narcolepsy	0.000193	0.0009	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TAC1—narcolepsy	0.000193	0.000898	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NPS—narcolepsy	0.000193	0.000898	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TRH—narcolepsy	0.000192	0.000894	CbGpPWpGaD
Ponatinib—LYN—Immune System—HLA-DQB1—narcolepsy	0.000189	0.000882	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HLA-DQB1—narcolepsy	0.000189	0.000878	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HTR2A—narcolepsy	0.000182	0.000845	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HLA-DRB1—narcolepsy	0.000176	0.000818	CbGpPWpGaD
Ponatinib—KIT—Immune System—HLA-DRB1—narcolepsy	0.000173	0.000803	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000172	0.000802	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CPT1B—narcolepsy	0.000171	0.000797	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NPS—narcolepsy	0.00017	0.000792	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TAC1—narcolepsy	0.00017	0.000792	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TRH—narcolepsy	0.00017	0.000791	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HRH3—narcolepsy	0.000168	0.000784	CbGpPWpGaD
Ponatinib—LCK—Immune System—HLA-DQA1—narcolepsy	0.000166	0.000773	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HLA-DRB1—narcolepsy	0.000164	0.000762	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HLA-DRB1—narcolepsy	0.000163	0.00076	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HTR2A—narcolepsy	0.000158	0.000736	CbGpPWpGaD
Ponatinib—LCK—Immune System—HLA-DQB1—narcolepsy	0.000155	0.000723	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TNF—narcolepsy	0.00015	0.0007	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CPT1B—narcolepsy	0.000149	0.000694	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HRH3—narcolepsy	0.000149	0.000694	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-DQA1—narcolepsy	0.000147	0.000684	CbGpPWpGaD
Ponatinib—LYN—Immune System—HLA-DRB1—narcolepsy	0.000144	0.000671	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HLA-DRB1—narcolepsy	0.000143	0.000667	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000141	0.000654	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TAC1—narcolepsy	0.00014	0.000649	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NPS—narcolepsy	0.00014	0.000649	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-DQB1—narcolepsy	0.000137	0.00064	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CHKB—narcolepsy	0.000135	0.000629	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TNF—narcolepsy	0.000132	0.000616	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TNF—narcolepsy	0.000132	0.000613	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR2A—narcolepsy	0.000125	0.000581	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NPS—narcolepsy	0.000124	0.000575	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TAC1—narcolepsy	0.000124	0.000575	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR2A—narcolepsy	0.000123	0.000571	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000122	0.000566	CbGpPWpGaD
Ponatinib—LCK—Immune System—HLA-DRB1—narcolepsy	0.000118	0.00055	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR2A—narcolepsy	0.000116	0.000542	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR2A—narcolepsy	0.000116	0.00054	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-DRB1—narcolepsy	0.000105	0.000487	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR2A—narcolepsy	0.000102	0.000477	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—narcolepsy	9.61e-05	0.000447	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CPT1B—narcolepsy	9.19e-05	0.000428	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR2A—narcolepsy	8.39e-05	0.000391	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR2A—narcolepsy	7.43e-05	0.000346	CbGpPWpGaD
